Tarique Sayed, a Director, acquired 1,093,122 Subordinate Voting Shares on a direct ownership basis at prices ranging from $0.150 to $0.158 through a prospectus or prospectus exempt offering on May 4th, 2020. The insider also acquired 1,093,122 Warrants with an exercise price of $0.250 for 24 months. This represents a $170,000 investment into the company's shares and an account share holdings change of greater than 100%.
Devonian Health Group is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Devonian Health Group In is a late stage Canada-based botanical and pharmaceutical company. The Company adopts a therapeutic approach, which targets various worldwide unmet medical needs. The core business of the Company is the development of prescription botanical drugs, as well as derma-cosmeceutical products, which is divided into two main segments: Therapeutics and Derma-cosmeceuticals. The Therapeutics segment includes Thykamine, which is an active lead drug candidate confirmed in a number of pre-clinical and clinical studies targeting inflammation. The Derma-cosmeceuticals includes the first derma-cosmeceutical product of the Company, which is a women's anti-aging treatment consisting of day, night and eye creams.
No Comments